Literature DB >> 20549363

Psychiatric and cognitive profile in Anderson-Fabry patients: a preliminary study.

Perri Segal1, Yoav Kohn, Yehuda Pollak, Gheona Altarescu, Esti Galili-Weisstub, Annick Raas-Rothschild.   

Abstract

Anderson-Fabry disease (AFD) is an X-linked inherited lysosomal storage disorder disease caused by a deficiency in the activity of the alpha-galactosidase enzyme. We investigated neuropsychological and psychiatric function in AFD patients. We studied 16 AFD patients, aged 7 to 61 years. Intelligence, language, vision-spatial abilities, memory, sensorimotor abilities, and attention and executive functions were tested with a computerized test battery as well as standard paper and pencil tests. The results were compared to known age-based norms. In addition, all patients were screened for lifelong DSM-IV Axis-I and Axis-II psychiatric diagnoses, and 4 were interviewed by a psychiatrist. Performance on most cognitive measures was within average range. All measures of information processing speed were significantly reduced, as were some measures of executive functions. Ten out of 16 patients met DSM-IV criteria for Axis I or Axis II diagnoses at some point in their lives. This preliminary study delineates a psychiatric and cognitive phenotype in AFD patients and contributes to the growing field of characterizing behavioral phenotypes of patients with genetic diseases. We suggest that psychiatric and neuro-psychological evaluation be included in the patient's evaluation.

Entities:  

Mesh:

Year:  2010        PMID: 20549363     DOI: 10.1007/s10545-010-9133-3

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  43 in total

1.  The unity and diversity of executive functions and their contributions to complex "Frontal Lobe" tasks: a latent variable analysis.

Authors:  A Miyake; N P Friedman; M J Emerson; A H Witzki; A Howerter; T D Wager
Journal:  Cogn Psychol       Date:  2000-08       Impact factor: 3.468

2.  Standardized assessment of cognitive functioning during development and aging using an automated touchscreen battery.

Authors:  C Richard Clark; Robert H Paul; Leanne M Williams; Martijn Arns; Kamran Fallahpour; Carolyn Handmer; Evian Gordon
Journal:  Arch Clin Neuropsychol       Date:  2006-08-14       Impact factor: 2.813

3.  Psychosis in a patient with Fabry's disease and treatment with aripiprazole.

Authors:  Yu-Chih Shen; Lee Haw-Ming; Chaucer C H Lin; Chia-Hsiang Chen
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2006-12-22       Impact factor: 5.067

4.  White matter damage on diffusion tensor imaging correlates with age-related cognitive decline.

Authors:  R A Charlton; T R Barrick; D J McIntyre; Y Shen; M O'Sullivan; F A Howe; C A Clark; R G Morris; H S Markus
Journal:  Neurology       Date:  2006-01-24       Impact factor: 9.910

5.  Automated and visual scoring methods of cerebral white matter hyperintensities: relation with age and cognitive function.

Authors:  A M Tiehuis; K L Vincken; W P T M Mali; L J Kappelle; P Anbeek; A Algra; G J Biessels
Journal:  Cerebrovasc Dis       Date:  2007-11-22       Impact factor: 2.762

6.  The NUCOG: validity and reliability of a brief cognitive screening tool in neuropsychiatric patients.

Authors:  Mark Walterfang; Ronald Siu; Dennis Velakoulis
Journal:  Aust N Z J Psychiatry       Date:  2006 Nov-Dec       Impact factor: 5.744

7.  Psychological complications of patients with Gaucher disease.

Authors:  W Packman; T Wilson Crosbie; A Riesner; C Fairley; S Packman
Journal:  J Inherit Metab Dis       Date:  2006-02       Impact factor: 4.982

8.  Decreased nitric oxide bioavailability in a mouse model of Fabry disease.

Authors:  Liming Shu; James L Park; Jaeman Byun; Subramaniam Pennathur; Jessica Kollmeyer; James A Shayman
Journal:  J Am Soc Nephrol       Date:  2009-07-23       Impact factor: 10.121

9.  White matter lesions in Fabry disease occur in 'prior' selectively hypometabolic and hyperperfused brain regions.

Authors:  David F Moore; Gheona Altarescu; W Craig Barker; Nicholas J Patronas; Peter Herscovitch; Raphael Schiffmann
Journal:  Brain Res Bull       Date:  2003-12-30       Impact factor: 4.077

10.  White matter hyperintensities and subclinical infarction: associations with psychomotor speed and cognitive flexibility.

Authors:  Clinton B Wright; Joanne R Festa; Myunghee C Paik; Alexis Schmiedigen; Truman R Brown; Mitsuhiro Yoshita; Charles DeCarli; Ralph Sacco; Yaakov Stern
Journal:  Stroke       Date:  2008-02-07       Impact factor: 7.914

View more
  9 in total

1.  Cognitive Impairments and Subjective Cognitive Complaints in Fabry Disease: A Nationwide Study and Review of the Literature.

Authors:  Josefine Loeb; Ulla Feldt-Rasmussen; Christoffer Valdorff Madsen; Asmus Vogel
Journal:  JIMD Rep       Date:  2018-04-14

2.  Cognitive function in adults aging with fabry disease: a case-control feasibility study using telephone-based assessments.

Authors:  Virginia G Wadley; Leslie A McClure; David G Warnock; Caroline L Lassen-Greene; Robert J Hopkin; Dawn A Laney; Virginia M Clarke; Manjula Kurella Tamura; George Howard; Katherine Sims
Journal:  JIMD Rep       Date:  2015-01-08

3.  Cognitive and psychological functioning in Fabry disease.

Authors:  Linda Sigmundsdottir; Michel C Tchan; Alex A Knopman; Graham C Menzies; Jennifer Batchelor; David O Sillence
Journal:  Arch Clin Neuropsychol       Date:  2014-11       Impact factor: 2.813

Review 4.  The neuropsychiatry of inborn errors of metabolism.

Authors:  Mark Walterfang; Olivier Bonnot; Ramon Mocellin; Dennis Velakoulis
Journal:  J Inherit Metab Dis       Date:  2013-05-23       Impact factor: 4.982

5.  The Psychosocial Impact of Fabry Disease on Pediatric Patients.

Authors:  Nicolle Bugescu; Paige E Naylor; Kyr Hudson; Christa D Aoki; Matthew J Cordova; Wendy Packman
Journal:  J Pediatr Genet       Date:  2016-06-13

6.  Fabry disease: GLA deletion alters a canonical splice site in a family with neuropsychiatric manifestations.

Authors:  Patrícia Varela; Gerson Carvalho; Renan Paulo Martin; João Bosco Pesquero
Journal:  Metab Brain Dis       Date:  2020-11-06       Impact factor: 3.584

Review 7.  Cognitive dysfunction and depression in Fabry disease: a systematic review.

Authors:  Fay E Bolsover; Elaine Murphy; Lisa Cipolotti; David J Werring; Robin H Lachmann
Journal:  J Inherit Metab Dis       Date:  2013-08-16       Impact factor: 4.982

Review 8.  Fabry disease.

Authors:  Dominique P Germain
Journal:  Orphanet J Rare Dis       Date:  2010-11-22       Impact factor: 4.123

9.  Neuropsychiatric Symptoms and Their Association With Sex, Age, and Enzyme Replacement Therapy in Fabry Disease: A Systematic Review.

Authors:  Magdalena Mroczek; Ignazio Maniscalco; Manon Sendel; Ralf Baron; Erich Seifritz; Albina Nowak
Journal:  Front Psychiatry       Date:  2022-03-16       Impact factor: 4.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.